Boai NKY Pharmaceuticals Ltd operates in the Industrial organic chemicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boai NKY Pharmaceuticals Ltd with three other
companies in this sector in China:
JiangXi ChangJiu Biochemical Industry Company Limited
sales of 433.70 million Chinese Renmimbi [US$63.02 million]
of which 92%
Shandong Fengyuan Chemical Co Ltd
(256.43 million Chinese Renmimbi [US$37.26 million]
of which 37%
was Trade), and
Zhejiang Jiaao Enprotech Stock Co Ltd
(506.20 million Chinese Renmimbi [US$73.56 million]
of which 99%
was Plastic Additives).
Boai NKY Pharmaceuticals Ltd reported sales of 400.57 million Chinese Renmimbi (US$58.21 million)
December of 2016.
increase of 37.9%
versus 2015, when the company's sales were 290.47 million Chinese Renmimbi.
This was the third consecutive year of growth at Boai NKY Pharmaceuticals Ltd.
Sales of Medical Services saw an increase
that was more than double the company's growth rate: sales were up
144.4% in 2016, from
54.26 million Chinese Renmimbi to 132.60 million Chinese Renmimbi.